Connect Biopharma Holdings Limited operates as a clinical-stage biopharmaceutical company in the United States. It develops rademikibart, a human monoclonal IgG4 antibody directed against IL-4Ra in two Phase 2 trials for the treatment of ac...
Leadership
Barry D. Quart Pharm.D.
CEO & Director
David L. Szekeres J.D.
President
Lisa Peraza CPA
Senior Vice President of Finance
Jeff Cohn J.D.
General Counsel & Corporate Secretary
Sean T. Ristine
Vice President of Human Resources
Lei Sun Ph.D.
VP of Biologics & Head of CMC
Srikanth Pendyala M.D.
Senior Vice President of Clinical Development(Consultant)
